-
ABT-737 for Reliable Apoptosis Assays
2026-09-21
Learn how ABT-737 (SKU A8193) can improve mechanistic interpretation, dosing consistency, and vendor selection in cell viability and apoptosis workflows. This scenario-based guide connects BCL-2 family biology with practical stock preparation, controls, endpoint selection, and evidence-based assay troubleshooting.
-
KR-12 Antimicrobial Peptides: Design and Applications
2026-09-21
This review examines KR-12, a compact antimicrobial region derived from human LL-37, and explains how sequence engineering, conjugation, cyclization, nan formulation, and biomaterial immobilization can improve its activity and stability. Its practical significance lies in combining antibacterial, antibiofilm, endotoxin-neutralizing, and immune-regulatory functions while identifying the translational limitations that remain for peptide therapeutics.
-
NETs in CML and TKI-Linked Vascular Risk
2026-09-20
The reference study shows that neutrophil extracellular trap formation is elevated in treatment-naïve chronic myeloid leukemia and can be differentially modified by tyrosine kinase inhibitors. Its combination of patient-derived neutrophils, molecular NET markers, and a BCR-ABL1-transduced neutrophil model provides a mechanistic framework for investigating how leukemia biology and TKI-associated vascular toxicity may intersect.
-
Caspase-3 Fluorometric Assay Kit for Ferroptosis
2026-09-19
Connect executioner-caspase activity with ferroptosis–apoptosis crosstalk using a rapid DEVD-AFC fluorescence workflow. This guide combines practical assay setup, quantitative controls, and troubleshooting for cancer, neurodegeneration, and mechanistic cell-death studies.
-
SR 11302: AP-1 Transcription Factor Inhibitor
2026-09-19
SR 11302 is an AP-1 transcription factor inhibitor for preclinical cancer research. Product information describes selective AP-1 blockade without RAR or RXR activation, with activity reported in selected tumor-cell models and carcinogen-induced papilloma models.
-
PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma
2026-09-18
This 2025 Nature Communications study identifies PDHA1 lysine 83 succinylation as a metabolic-immune control point in cholangiocarcinoma. The modification increases PDHA1 activity, promotes tumor-microenvironmental α-ketoglutarate accumulation, suppresses macrophage MHC-II antigen presentation through OXGR1-MAPK signaling, and may contribute to resistance to gemcitabine–cisplatin chemotherapy.
-
ZIF8 Nanotheranostics for Triple-Negative Breast Cancer
2026-09-18
Li et al. developed FA-PEG@ZIF8@CIP, an ultrasound-responsive nanotheranostic platform that combines folic acid-mediated targeting, pH-responsive Ciprofloxacin release, sonodynamic therapy, chemotherapy, and immune activation. In TNBC models, ultrasound-enhanced treatment increased reactive oxygen species, promoted immunogenic cell death, improved cytotoxic T-cell infiltration, and supported ultrasound imaging-guided therapy.
-
FTH-Linked Ferroptosis in TP53-Mutant Glioblastoma
2026-09-17
The reference study identifies an iron-homeostasis mechanism in which gain-of-function TP53 mutations increase ITCH expression, promote FTH degradation, and expand the free-iron pool in glioblastoma models. This state creates a context-dependent vulnerability to Erastin, particularly when combined with ferric ammonium citrate, while also revealing why TP53-mutant cells can tolerate iron stress before undergoing ferroptosis.
-
Bacitracin (B1670): Practical Research Guide
2026-09-17
Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. This guide covers stock preparation, solvent controls, QC, and interpretation boundaries; the material is for scientific research only and not for diagnostic, therapeutic, or medical use.
-
Lipid Nanoparticles and Tissue-Specific T Cells
2026-09-16
The reference study shows that lipid nanoparticle composition can control systemic trafficking after intramuscular injection and thereby shape organ-specific antigen expression and CD8+ tissue-resident memory T-cell responses. Its findings connect formulation chemistry with localized immunity, providing a framework for designing mRNA vaccines and therapeutic studies around tissue-level protection rather than systemic responses alone.
-
Mycophenolic Acid: Dehydrogenase Inhibitor Guide
2026-09-15
Mycophenolic acid is a dehydrogenase inhibitor that suppresses inosine monophosphate dehydrogenase and constrains guanine-nucleotide biosynthesis. This research-focused guide connects its biochemical rationale with standardized whole-blood immune assays, handling requirements, and experimental limitations.
-
Saracatinib: From Src Signaling to Translation
2026-09-15
Saracatinib (AZD0530) offers translational researchers a way to interrogate Src family kinase and Abl signaling across cancer models while opening a carefully bounded bridge to synaptic biology. This article connects pathway mechanism, assay design, xenograft interpretation, and the Reelin–Apoer2–SFK findings reported in a key ketamine study.
-
Hoechst 33258 for KRas TNT Imaging
2026-09-14
Use Hoechst 33258 as a live-compatible nuclear readout when studying KRas-driven heterogeneity, tunneling nanotubes, and cell mechanics. This workflow combines DNA staining, confocal imaging, cell-cycle profiling, and quantitative nuclear segmentation without treating the stain itself as a direct KRas or TNT marker.
-
Hyperforin–Dlat–Trpv3 Adipose Thermogenesis
2026-09-14
The reference study identifies a non-canonical Dlat–Trpv3–Ca2+–CaMKKβ–AMPK pathway through which hyperforin promotes adipose thermogenesis and counters diet-associated obesity. Its combination of genetic, metabolic, cellular, pharmacokinetic, and imaging evidence positions Dlat-dependent calcium signaling as a useful alternative framework to β3-adrenergic receptor agonism.
-
Cefepime in Resistance and CNS Infection Models
2026-09-13
Cefepime (BMY-28142) is a practical probe for linking antimicrobial phenotype, carbapenemase-gene mobility, and exposure-related neurotoxicity in research models. This guide translates a recent Enterobacter cloacae surveillance study into reproducible assay workflows while keeping CNS applications, resistance interpretation, and safety boundaries distinct.